Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derrick W Crook

Showing results (11-20 of 249) with videos related to

Pageof 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infectionPamela Sears, Derrick W Crook, Thomas J Louie, et al.
The Lancet. Microbe|May 11, 2022
Antimicrobial resistance genes and clonal success in Escherichia coli isolates causing bloodstream infectionSam Lipworth, Timothy Ea Peto, Derrick W Crook, et al.
Nature Reviews. Microbiology|January 26, 2016
Within-host evolution of bacterial pathogensXavier Didelot, A Sarah Walker, Tim E Peto, et al.
Nature Reviews. Genetics|August 8, 2012
Transforming clinical microbiology with bacterial genome sequencingXavier Didelot, Rory Bowden, Daniel J Wilson, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Site-specific recombination with the chromosomal tRNA(Leu) gene by the large conjugative Haemophilus resistance plasmidIoanna D Dimopoulou, Joanne E Russell, Zaini Mohd-Zain, et al.
The Lancet. Infectious Diseases|January 18, 2016
Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniaeNicole Stoesser, Amy J Mathers, Catrin E Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycinOliver A Cornely, Mark A Miller, Thomas J Louie, et al.
BMJ Open Gastroenterology|October 14, 2015
Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoeaKarl Weiss, Thomas Louie, Mark A Miller, et al.
Microbial Genomics|June 20, 2020
Evaluation of methods for detecting human reads in microbial sequencing datasetsStephen J Bush, Thomas R Connor, Tim E A Peto, et al.
BMJ (Clinical Research Ed.)|November 22, 2008
Fairness of financial penalties to improve control of Clostridium difficileA Sarah Walker, David Spiegelhalter, Derrick W Crook, et al.
Pageof 25

Showing results (11-20 of 249) with videos related to

Sort By:
Pageof 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infectionPamela Sears, Derrick W Crook, Thomas J Louie, et al.
The Lancet. Microbe|May 11, 2022
Antimicrobial resistance genes and clonal success in Escherichia coli isolates causing bloodstream infectionSam Lipworth, Timothy Ea Peto, Derrick W Crook, et al.
Nature Reviews. Microbiology|January 26, 2016
Within-host evolution of bacterial pathogensXavier Didelot, A Sarah Walker, Tim E Peto, et al.
Nature Reviews. Genetics|August 8, 2012
Transforming clinical microbiology with bacterial genome sequencingXavier Didelot, Rory Bowden, Daniel J Wilson, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Site-specific recombination with the chromosomal tRNA(Leu) gene by the large conjugative Haemophilus resistance plasmidIoanna D Dimopoulou, Joanne E Russell, Zaini Mohd-Zain, et al.
The Lancet. Infectious Diseases|January 18, 2016
Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniaeNicole Stoesser, Amy J Mathers, Catrin E Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycinOliver A Cornely, Mark A Miller, Thomas J Louie, et al.
BMJ Open Gastroenterology|October 14, 2015
Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoeaKarl Weiss, Thomas Louie, Mark A Miller, et al.
Microbial Genomics|June 20, 2020
Evaluation of methods for detecting human reads in microbial sequencing datasetsStephen J Bush, Thomas R Connor, Tim E A Peto, et al.
BMJ (Clinical Research Ed.)|November 22, 2008
Fairness of financial penalties to improve control of Clostridium difficileA Sarah Walker, David Spiegelhalter, Derrick W Crook, et al.
Pageof 25